Millions of Americans could now be eligible for Medicare to cover their prescriptions of the popular weight loss drug Wegovy, according to a new analysis by KFF. The highly coveted medication belongs to the same class of drug as diabetes medication Ozempic, which is also known for its weight loss side effects.